3.0.0 4570 2026-03-31T12:34:02Z 2026-03-31T12:34:02Z House H HR 2025-07-21 119 https://www.congress.gov/bill/119th-congress/house-bill/4570 [Congressional Record Volume 171, Number 124 (Monday, July 21, 2025)][House][Pages H3527-H3528]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. NEGUSE:H.R. 4570.[[Page H3528]]Congress has the power to enact this legislation pursuantto the following:Article I, Section 8]]> hsju00 Judiciary Committee House Standing Referred To 2025-07-21T16:01:30Z Interagency Patent Coordination and Improvement Act of 2025 119 1097 S 2025-04-10 Placed on Senate Legislative Calendar under General Orders. Calendar No. 41. Related bill CRS 2025-07-21 Referred to the House Committee on the Judiciary. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2025-07-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2025-07-21 Introduced in House IntroReferral 1000 9 Library of Congress N000191 Rep. Neguse, Joe [D-CO-2] Joe Neguse D CO 2 N Commerce Commerce 2025-09-11T17:07:21Z 00 2025-07-21 Introduced in House 2026-03-31T12:31:00Z Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

]]> Interagency Patent Coordination and Improvement Act of 2025 Display Title 45 Interagency Patent Coordination and Improvement Act of 2025 2025-07-31T04:43:19Z Short Title(s) as Introduced 101 Interagency Patent Coordination and Improvement Act of 2025 2025-07-31T04:43:17Z Introduced in House IH Official Title as Introduced 6 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. 2025-07-31T04:33:32Z Introduced in House IH Introduced in House 2025-07-21T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119hr4570ih/xml/BILLS-119hr4570ih.xml 2025-07-21 Referred to the House Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.